Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03568188
What this trial is testing

Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 174
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07300566
What this trial is testing

Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial

Who this might be right for
Prostate Cancer
Joelle Helou 58
Not applicableStudy completedNCT03790995
What this trial is testing

Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP

Who this might be right for
Prostate CancerQuality of LifeErectile Function+1 more
KU Leuven 9,235
Large-scale testing (Phase 3)Active Not RecruitingNCT03367702
What this trial is testing

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Who this might be right for
Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology 692
Not applicableStudy completedNCT01599182
What this trial is testing

Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Waterloo 9
Not applicableUnknownNCT04656678
What this trial is testing

Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CancerProstate Disease
Northwell Health 200
Testing effectiveness (Phase 2)Study completedNCT03124433
What this trial is testing

Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer

Who this might be right for
Cancer of the Prostate
Singapore General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00583492
What this trial is testing

Randomized Trial of Suicide Gene Therapy and Prostate Cancer

Who this might be right for
Prostate Cancer
Henry Ford Health System 44
Not applicableTemporarily pausedNCT06144619
What this trial is testing

Non-Invasive Biomarkers in Prostate Cancer Disease Management

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 500
Post-approval studies (Phase 4)UnknownNCT01581749
What this trial is testing

Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Neoplasms
Albert DeNittis 50
Not applicableUnknownNCT03225235
What this trial is testing

Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
The Greater Poland Cancer Centre 600
Post-approval studies (Phase 4)Active Not RecruitingNCT06627530
What this trial is testing

COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer

Who this might be right for
Prostate Cancer
Brazilian Clinical Research Institute 144
Testing effectiveness (Phase 2)Looking for participantsNCT06678126
What this trial is testing

Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP)

Who this might be right for
Prostate Cancer
Scott Tyldesley 104
Not applicableNot Yet RecruitingNCT07132658
What this trial is testing

MRI-guided Ultrahypofractionated SBRT Prostate Program

Who this might be right for
Prostate Cancer
Clinica Universidad de Navarra, Universidad de Navarra 40
Not applicableStudy completedNCT01368055
What this trial is testing

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Florida 361
Testing effectiveness (Phase 2)WithdrawnNCT01409473
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Rocky Mountain Cancer Centers
Not applicableLooking for participantsNCT04035642
What this trial is testing

Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)

Who this might be right for
Prostate Cancer
Fundacao Champalimaud 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04597359
What this trial is testing

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Who this might be right for
Prostate Carcinoma
ECOG-ACRIN Cancer Research Group 360
Large-scale testing (Phase 3)Active Not RecruitingNCT00223145
What this trial is testing

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

Who this might be right for
Prostate Cancer
Abdenour Nabid 600
Early research (Phase 1)Study completedNCT03269422
What this trial is testing

Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 35
Next Page